---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-21-002041"
form_type: "8-K"
ticker: "BDPT"
cik: "0001575142"
company_name: "BIOADAPTIVES, INC."
filed_at: "2021-08-27T23:59:59+00:00"
generated_at: "2026-06-29T07:19:02.767394+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# BioAdaptives partners with Stanford professor to study PluriPain for Gadolinium Deposition Disease pain

## Summary
- Collaboration with Stanford's Prof. Lorrin Koran to research PluriPain for pain relief in Gadolinium Deposition Disease.
- PluriPain used for analgesic/anti-inflammatory effects; no drug claims are made for treating the disease.
- Gadolinium Deposition Disease is a rare disorder caused by MRI contrast agent, leading to chronic pain.
- BioAdaptives' role is limited to providing PluriPain for Dr. Koran's research.

## SEC filing metadata
- accession: 0001640334-21-002041
- form_type: 8-K
- ticker: BDPT
- cik: 0001575142
- company_name: BIOADAPTIVES, INC.
- filed_at: 2021-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1575142/000164033421002041/0001640334-21-002041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1575142/000164033421002041/bdpt_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-21-002041
- JSON: https://secwatch.observer/filing/0001640334-21-002041.json
- Plain text: https://secwatch.observer/filing/0001640334-21-002041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.